Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Microenvironment”

277 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 277 results

Early research (Phase 1)Ended earlyNCT02309892
What this trial is testing

A Dose Escalation Study of L-DOS47 in Recurrent or Metastatic Non-Squamous NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Helix BioPharma Corporation 14
Not applicableUnknownNCT06007989
What this trial is testing

Assessing the Relationship Between Hypoxia and the Immune Environment in Myeloma Patients (CHIME)

Who this might be right for
Myeloma
The Christie NHS Foundation Trust 10
Not applicableStudy completedNCT03060642
What this trial is testing

The Microenvironment in Barrett's Esophagus

Who this might be right for
Barrett EsophagusEsophageal Adenocarcinoma
Columbia University 155
Very early researchEnded earlyNCT03519308
What this trial is testing

A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Abramson Cancer Center at Penn Medicine 3
Not applicableLooking for participantsNCT05038358
What this trial is testing

Tumor Immune Microenvironment Involvement in Colorectal Cancer Chemoresistance Mechanisms

Who this might be right for
Primary TumorColon Tumor
University Hospital, Grenoble 60
Not applicableActive Not RecruitingNCT03165487
What this trial is testing

Comparison of the Breast Tumor Microenvironment

Who this might be right for
Triple Negative Breast CancerHormone Receptor Positive Malignant Neoplasm of Breast
Columbia University 14
Testing effectiveness (Phase 2)Study completedNCT01030900
What this trial is testing

Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas

Who this might be right for
Hodgkin LymphomaDiffuse Large B-Cell Lymphoma
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Ended earlyNCT02959437
What this trial is testing

Azacitidine Combined With Pembrolizumab and Epacadostat in Subjects With Advanced Solid Tumors (ECHO-206)

Who this might be right for
Solid TumorsAdvanced MalignanciesMetastatic Cancer
Incyte Corporation 70
Not applicableLooking for participantsNCT05644431
What this trial is testing

GastrOesophageal Tumor, Immune Microenvionnment (GOTIM)

Who this might be right for
GastroEsophageal Cancer
Centre Leon Berard 50
Not applicableStudy completedNCT06381895
What this trial is testing

The Efficacy of Radiomics to Predict Tumor Microenvironment Markers and Comprehensive Therapy for Bladder Cancer

Who this might be right for
Bladder CancerRadiomicsImmunotherapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 1,200
Not applicableUnknownNCT05677724
What this trial is testing

Single-cell RNA Sequencing Resolves the Regulatory Role of HBV on the Hepatocellular Carcinoma Immune Microenvironment

Who this might be right for
HBVPrimary Liver Cancer
Fubing Wang 20
Early research (Phase 1)Ended earlyNCT03277209
What this trial is testing

To Assess the Safety of Continuous IV Administration of Plerixafor and Assess Impact on the Immune Microenvironment in Patients With Pancreatic, Ovarian and Colorectal Adenocarcinomas

Who this might be right for
Pancreas Cancer
Weill Medical College of Cornell University 2
Not applicableLooking for participantsNCT06946745
What this trial is testing

Exploration of the Dynamic Changes and Mechanisms of the Immune Microenvironment in Advanced Colorectal Cancer Treated With IBI363 Combination Therapy

Who this might be right for
Immunotherapy
jianming xu 50
Not applicableNot Yet RecruitingNCT06827639
What this trial is testing

In-depth Characterization of Circulating and Infiltrating Immune Subsets and Tumor Cells in Cancer Patients

Who this might be right for
Head and Neck CancerUrologic CancerLung Cancer+2 more
Assistance Publique Hopitaux De Marseille 640
Not applicableStudy completedNCT06293612
What this trial is testing

Constructing a Multimodal Imaging System to Predict the Risk of Heterochronous Metastasis of Rectal Cancer

Who this might be right for
Locally Advanced Rectal CancerDistant Metastasis
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 302
Not applicableLooking for participantsNCT06182657
What this trial is testing

The Prognostic Value of the Degree of Pathological Response of Induction Chemotherapy for NPC

Who this might be right for
Nasopharyngeal CarcinomaPathologic Complete ResponseTumor Microenvironment
Jiangxi Provincial Cancer Hospital 300
Not applicableUnknownNCT04749407
What this trial is testing

Biomarkers of Stage III Locally Advanced Unresectable Non-small-cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage III
First People's Hospital of Hangzhou 50
Very early researchStudy completedNCT05250895
What this trial is testing

BOLD MRI and FMISO PET for the Assessment of Hypoxic Tumor Microenvironment in Patients with Oligometastatic Liver Cancer Undergoing Yttirum-90 Selective Internal Radiation Therapy

Who this might be right for
BCLC Stage a Hepatocellular CarcinomaBCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular Carcinoma+1 more
Emory University 9
Testing effectiveness (Phase 2)WithdrawnNCT03532087
What this trial is testing

Study to Identify the Impact of Denosumab on the Immune System in Patients With HER2 Negative Breast Cancer

Who this might be right for
Breast Neoplasms
Borstkanker Onderzoek Groep
Early research (Phase 1)Active Not RecruitingNCT05081479
What this trial is testing

N-Acetylcysteine (N-AC) in People Receiving CAR T-cell Therapy for Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center 9
Load More Results